Skip to main content
Clinical Trials/NCT05718830
NCT05718830
Completed
Not Applicable

Selecting Specific Bio-markers and Researching Mechanisms of Immune Regulation From Inhalation Injury and Traumatic Lung Injury Based on Single Cell Sequencing Technology

Changhai Hospital1 site in 1 country21 target enrollmentJanuary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Traumatic Lung Injury
Sponsor
Changhai Hospital
Enrollment
21
Locations
1
Primary Endpoint
Partial pressure of carbon dioxide in arterial blood, PaCO2
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The goal of this observational study is to profile the circulating immunological traits of patients with traumatic lung injury (TLI) and inhalation injury (ILI),providing a new direction for the depth research of the pathogenesis, and providing new immune-related targets for diagnosis of the severity of lung injury and treatment.

The investigators performed scRNA-seq of neutrophil and peripheral blood mononuclear cells (PBMCs) from 10 ml fresh circulating blood from 3 patients with TLI and 3 patients with ILI at longitudinal timepoints,as well as peripheral blood from 3 health controls(HCs).

Detailed Description

The investigators performed single-cell transcriptomic sequencing (BD Rhapsody) on neutrophil and PBMCs extracted from the fresh circulating blood from 3 patients with TLI and 3 patients with ILI at longitudinal timepoints,as well as peripheral blood from 3 health controls(HCs). Three time points are picked by clinical conditions of patients with TLI or ILI: day 1 post hospital admission, day 3 post hospital and the day before discharged which matched to acute stage,progressive stage and convalescence.

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
December 31, 2021
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Lung injury caused by burn trauma is confirmed, and the patient is hospitalized within 24 hours after burn or trauma (the clinician can make a definite diagnosis of lung injury based on the comprehensive judgment of the patient's etiology, history, clinical manifestations, blood gas analysis, laboratory tests and imaging);
  • Patients with inhalation injury caused by head, face and neck burns or inhalation injury combined with multiple body burns \< 30%;
  • Patients with simple inhalation injury;
  • The normal control group should have no smoking history and be normal population;
  • According to the provisions of Good Clinical Practice(GCP), the informed consent has been obtained and the informed consent has been signed to volunteer for the test.

Exclusion Criteria

  • Basic pulmonary diseases like chronic obstructive pulmonary disease (COPD), asthma and et al;
  • Severe organ dysfunction;
  • Autoimmune diseases;
  • Severe infection;
  • Pregnant or nursing women;
  • Fatal or life-threatening events caused by trauma;
  • Any history which may interfere the results or increase the risk of patients judged by researchers.

Outcomes

Primary Outcomes

Partial pressure of carbon dioxide in arterial blood, PaCO2

Time Frame: through study completion, an average of 2 weeks

Computerized tomography, CT

Time Frame: through study completion, an average of 2 weeks

according to the proportion of rib fracture, pneumothorax, hemothorax,lung contusion in the image

Oxygenation index and Fraction of Inspired Oxygen will be combined to report FiO2/PaO2

Time Frame: through study completion, an average of 2 weeks

Study Sites (1)

Loading locations...

Similar Trials